Evaluating the benefits of stocking and heparin in DVT preventio
- Conditions
- Venous thromboembolismCirculatory SystemPrevention of venous thromboembolism (VTE) in patients undergoing surgery
- Registration Number
- ISRCTN13911492
- Lead Sponsor
- Imperial College London
- Brief Summary
2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/28396238 protocol 2020 Results article in https://doi.org/10.1136/bmj.m1309 results (added 10/06/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33275096/ results (added 07/12/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1905
Current inclusion criteria as of 26/04/2018:
1. Aged 18 years or over (from Jan 2018 recruitment will be restricted to patients aged 65 years and above)
2. Capacity to provide informed consent
3. Elective surgical inpatients at a participating hospital
4. Moderate or high risk of venous thromboembolism (VTE)
Previous inclusion criteria:
1. Aged 18 years or over
2. Capacity to provide informed consent
3. Elective surgical inpatients at a participating hopsital
4. Moderate or high risk of venous thromboembolism (VTE)
1. Contraindications to low molecular weight heparin (LMWH)
2. Contraindications to graduated compression stockings (GCS), including peripheral arterial disease, stroke patients,
individuals undergoing lower limb surgery
3. Documented or known thrombophilia or thrombogenic disorder
4. Individuals requiring therapeutic anticoagulation
5. Previous venous thromboembolism (VTE)
6. Patients having intermittent pneumatic compression (IPC) beyond theatre and recovery
7. Patients requiring inferior vena cava (IVC) filter
8. Pregnancy
9. Patients requiring extended thromboprophylaxis
10. Application of a cast or brace in theatre
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method